MedTrace Logo

Study Assessing the Efficacy of Eductyl® for the Treatment of Patients With Dyschesia

NCT01243723 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 306

Last updated 2014-03-19

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of Eductyl versus placebo for treatment of patients with dyschesia.

Conditions

  • Dyschesia

Interventions

DRUG

Eductyl suppository

One suppository every morning during 21 days

DRUG

Placebo suppository

One suppository every morning during 21 days

Sponsors & Collaborators

  • Laboratoires Techni Pharma

    lead INDUSTRY

Principal Investigators

  • Anne-Laure Tarrerias, Dr · Suresnes Hospital

  • Bernard Savarieau, Dr · Nukleus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-03-31
Completion
2012-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01243723 on ClinicalTrials.gov